首页 | 本学科首页   官方微博 | 高级检索  
     

MiR-590-3p在胰腺癌干细胞中的表达
引用本文:宫伟强,秦仁义,王敏,田锐,朱峰,石程剑,张志发,李旭,洪晓泉. MiR-590-3p在胰腺癌干细胞中的表达[J]. 中华胰腺病杂志, 2011, 11(4). DOI: 10.3760/cma.j.issn.1674-1935.2011.04.006
作者姓名:宫伟强  秦仁义  王敏  田锐  朱峰  石程剑  张志发  李旭  洪晓泉
作者单位:1. 430030武汉,华中科技大学同济医学院附属同济医院胆胰外科;潍坊市人民医院肝胆外科
2. 华中科技大学同济医学院附属同济医院胆胰外科,武汉,430030
基金项目:国家自然科学基金面上项目
摘    要:目的 应用无血清培养基分离胰腺癌干细胞,检测其miR-590-3p的表达。方法 运用无血清培养基克隆培养ASPC-1、PANC1细胞,检测其单克隆形成、分化及细胞周期、半数抑制浓度(IC50)和表面标记物CD24+、CD44+表达。实时定量PCR法检测细胞miR-590-3p的表达。结果 经无血清培养基培养,(0.94±0.53)%的ASPC-1细胞和(0.57±0.12)%的PANC1细胞能存活,呈克隆球样悬浮生长,并可以在体外连续传代。加入血清后细胞球又重新贴壁生长。ASPC-1细胞球G0/G1期比例和CD24+、C44+、CD24+ CD44+的细胞比例及IC50分别为(75.3±5.4)%、0.96%~2.01%、27.52%~34.47%、0.35% ~0.44%和(224.37±5.71) μg/ml,均显著高于亲本细胞的(43.7±3.8)%、0.38%~0.42%、17.65% ~ 18.25%、0.05%~ 0.08%、(11.43±2.10) μg/ml(P值均<0.05)。PANC1细胞球G0/G1期比例和CD24+、CD44+、CD24 +CD44+的细胞比例及IC50分别为(80.1±4.7)%、5.31% ~9.84%、72.05% ~93.06%、4.91% ~5.21%、(296.58±4.27) μg/ml,均显著高于亲本细胞的(46.1±5.3)%、4.09%~4.97%、47.71%~55.66%、1.48% ~2.63%、(26.17±3.81) μg/ml(P值均<0.05)。ASPC-1、PANC1细胞球miR-590-3p表达分别是亲本细胞的4.67和4.52倍。结论 应用无血清培养基可以从ASPC-1、PANC1细胞系中分离出具有干细胞特性的胰腺癌细胞球,其miR-590-3p表达上调,该基因可能是胰腺癌干细胞特性维持的关键基因。

关 键 词:胰腺肿瘤  肿瘤干细胞  微RNAs  细胞球  无血清培养基

Expression of miR-590-3p in pancreatic cancer stem cells
GONG Wei-qiang,QIN Ren-yi,WANG Min,TIAN Pui,ZHU Feng,SHI Cheng-jian,ZHANG Zhi-fa,LI Xu,HONG Xiao-quan. Expression of miR-590-3p in pancreatic cancer stem cells[J]. CHINESE JOURNAL OF PANCREATOLOGY, 2011, 11(4). DOI: 10.3760/cma.j.issn.1674-1935.2011.04.006
Authors:GONG Wei-qiang  QIN Ren-yi  WANG Min  TIAN Pui  ZHU Feng  SHI Cheng-jian  ZHANG Zhi-fa  LI Xu  HONG Xiao-quan
Abstract:Objectives To isolate cancer stem cells (CSCs) in pancreatic cancer cell lines PANC1 and ASPC-1 with serum-free medium( SFM ), and to detect the expression of miR-590-3p in CSCs. Methods PANC1 and ASPC-1 cells was cultured in serum-free medium. The monoclonal formation, differentiation and cell cycle, half inhibitory concentration ( IC50 ), and the expression of the surface markers CD24 + , CD44 + were detected. qRT-PCR was used to detect the expression of miR-590-3p. Results After SFM culture, (0.94 ±0.53 ) % of ASPC-1 and (0.57 + 0. 12 ) % PANC1 survived, and they formed spheres, and could continuously passage in vitro. Cell spheres differentiation recurred when serum was supplemented in SFM. The G0/G1 stage proportion, CD24+ , CD44 + , CD24+ CD44+ cells proportion, IC50 in ASPC-1 cell were (75.3 ± 5.4)%,0.96% ~ 2.01%, 27.52% ~ 34.47%, 0.35% ~ 0.44% and (224.37 ± 5.71 ) μg/ml, which were significantly higher than that those in parent cell [ (43.7 ± 3.8 ) %, 0. 38% ~ 0.42%, 17.65% ~ 18.25%,0.05% ~0.08%, (11.43 ±2.10)μg/ml, P<0.05]. The G0/G1 stage proportion, CD24+ ,CD44+ ,CD24 +CD44 + cells proportion, IC50 in PANC 1 cell were ( 80. 1 ± 4.7) %, 5.31% ~ 9.84%, 72.05% ~ 93.06%,4.91% ~5.21%, (296.58±4.27) μg/ml, which were significantly higher than that those in parent cell [ (46.1 ±5.3)%, 4.09% ~4.97%, 47.71% ~55.66%, 1.48% ~2.63%, (26.17 ±3.81)μg/ml, P<0.05]. The expression of miR-590-3p in ASPC-1, PANC1 spheres was 4.67 and 4.52 times higher than the expression in parent cell lines. Conclusions Pancreatic cancer cell spheres can be isolated from ASPC-1, PANC1 by culture with SFM. miR-590-3p is up-regulated and may play an important role in regulating biological characteristics of pancreatic cancer stem cells.
Keywords:Pancreatic neoplasms  Tumor stem cells  MicroRNAs  Cell spheres  Serum-free medium
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号